Significant
Global Market Opportunities
- “Global OAB market size is expected to hit around USD
8.2 billion by 2030 from valued at
USD 3.9 billion in 2022 and growing at a CAGR of 4.6% from 2022 to 2030.”1
- Total economic impact of OAB estimate at $82B, including 75% in direct spend2,3.
- Only 5% of candidates for an advanced therapy receive treatment
- Only 40% of Americans with OAB symptoms seek medical attention due to embarrassment,
misconception that leaking is part of aging, etc.
- 80%+ of patients prescribed medications discontinue use within 6 months based on unmet
treatment expectations, adverse effects, and cost
- Over 200M people worldwide suffer from OAB
- Approximately 46 million American adults over the age of 40 have reported symptoms of
overactive bladder
- There is a significant needs for device therapy that is affordable, with no
complication, and used at home
- Nova one advisor
- Coyne, K. S., et al. (2014). Economic burden of urgency urinary incontinence in the United
States: a systematic review. Journal of managed care pharmacy : JMCP, 20(2), 130–140.
- Ganz, M. L., et al. (2010). Economic costs of overactive bladder in the United States.
Urology, 75(3), 526-532.